Loading…
Valion Bio, Inc. is projected to decline to $0.7272 by 2027, a -17% move from its current price of $0.879. VBIO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.8251 | $0.8786 | $0.9356 | -0.05% |
| May 30 | $0.8035 | $0.8782 | $0.9598 | -0.09% |
| May 31 | $0.7873 | $0.8778 | $0.9787 | -0.14% |
| Jun 1 | $0.7738 | $0.8774 | $0.9948 | -0.18% |
| Jun 2 | $0.7621 | $0.877 | $1.01 | -0.23% |
| Jun 3 | $0.7516 | $0.8766 | $1.02 | -0.28% |
| Jun 4 | $0.742 | $0.8762 | $1.03 | -0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.742 | $0.8762 | $1.03 | -0.32% |
| Week 2 | $0.6904 | $0.8734 | $1.10 | -0.64% |
| Week 3 | $0.6528 | $0.8706 | $1.16 | -0.96% |
| Week 4 | $0.6224 | $0.8678 | $1.21 | -1.28% |
| Week 5 | $0.5965 | $0.865 | $1.25 | -1.60% |
| Week 6 | $0.5739 | $0.8622 | $1.30 | -1.91% |
| Week 7 | $0.5537 | $0.8594 | $1.33 | -2.23% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Valion Bio, Inc. is a healthcare company that operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist in late-stage development to treat acute radiation syndrome.
The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc.
and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Valion Bio, Inc. (VBIO) is a healthcare company currently trading at $0.8524 and has a market cap of $2.73M. It ranks 5446 by market cap. The forecast outlook shows a path from a 2026 average price near current levels to higher levels in the following years, with 2030 averaging $1.07 and 2050 averaging $3.18, and corresponding bullish sentiment in the longer term.
A major floor 49.7% below — a decisive break under it would weaken the trend.
The nearest floor, 7.6% below — buyers have tended to step in here.
The nearest ceiling, 59.3% above — a clean break opens room to run.
A major ceiling 84.1% above — clearing it would confirm fresh momentum.
Key VBIO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VBIO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.8714 | Buy | $0.8743 | Buy |
| MA 10 | $0.8808 | Sell | $0.897 | Sell |
| MA 20 | $0.9481 | Sell | $0.9408 | Sell |
| MA 50 | $0.9992 | Sell | $0.9981 | Sell |
| MA 100 | $1.02 | Sell | $1.20 | Sell |
| MA 200 | $1.80 | Sell | $2.73 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.32 | Neutral |
| Stoch RSI (14) | 35.19 | Neutral |
| CCI (20) | -63.89 | Neutral |
| Williams %R (14) | -77.52 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | -8.44 | Sell |
| Bollinger %B (20,2) | 0.29 | Neutral |
| Stochastic %K (14) | 22.48 | Neutral |
| TRIX (15) | -0.49 | Sell |
| Awesome (5,34) | -0.14 | Sell |
| Ultimate (7,14,28) | 45.66 | Neutral |
| Momentum (10) | -0.22 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 0.87 | Buy |
| ADX (14) | 12.11 | Neutral |
| ATR (14) | 0.05 | Info |
Bearish sentiment is indicated in the near term. RSI(14) is 40, and the price is trading below the SMA(50) of $1.00 and well below the SMA(200) of $1.83. Support is at $0.812 and resistance at $1.40; the 30-day range spans $0.5502 to $1.32.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.745 | $0.879 | $1.30 | 0% | Neutral | |
| $0.5234 | $0.7272 | $1.09 | -17% | Bearish | |
| $0.4677 | $0.6897 | $1.10 | -22% | Bearish | |
| $0.6515 | $1.01 | $1.70 | +15% | Neutral | |
| $0.6866 | $1.12 | $1.95 | +27% | Bullish | |
| $0.6641 | $1.13 | $2.04 | +28% | Bullish | |
| $0.6273 | $1.11 | $2.07 | +26% | Bullish | |
| $0.5461 | $1.01 | $1.92 | +15% | Neutral | |
| $0.5078 | $0.9747 | $1.91 | +11% | Neutral | |
| $0.4786 | $0.9549 | $1.91 | +9% | Neutral | |
| $0.5579 | $1.24 | $2.73 | +41% | Bullish | |
| $1.47 | $3.27 | $7.52 | +272% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.745 | $0.879 | $1.05 | +0.00% |
| June 2026 | $0.7301 | $0.8756 | $1.09 | -0.39% |
| July 2026 | $0.6911 | $0.8429 | $1.07 | -3.73% |
| August 2026 | $0.73 | $0.9023 | $1.17 | +7.04% |
| September 2026 | $0.7739 | $0.9671 | $1.28 | +7.19% |
| October 2026 | $0.7424 | $0.9373 | $1.25 | -3.08% |
| November 2026 | $0.7165 | $0.9128 | $1.24 | -2.61% |
| December 2026 | $0.7371 | $0.9473 | $1.30 | +3.77% |
Click any year to see its month-by-month VBIO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Valion Bio, Inc.'s 2026 outlook centres on $0.879, within a $0.745 to $1.30 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, VBIO could reach as high as $1.09, with a base case around $0.7272 and support toward $0.5234 — roughly -17% from $0.879. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect VBIO to range from $0.4677 to $1.10 through 2028. The $0.6897 average target implies a -22% move from current prices. That is -5% versus the projected 2027 average. Expect choppier, lower action through this leg of the cycle.
The VBIO price prediction for 2029 points to an average of $1.01 (low $0.6515, high $1.70) — a potential gain of +15% on today's $0.879. Price action looks broadly range-bound.
In 2030, VBIO is projected to trade between $0.6866 and $1.95, averaging $1.12 — a potential gain of +27% from today's $0.879. That is up +10% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Valion Bio, Inc.'s 2031 outlook centres on $1.13, within a $0.6641 to $2.04 range. That is up +1% on the projected 2030 average. That marks a +28% change versus current levels. Momentum favours further upside here.
By 2032, VBIO could reach as high as $2.07, with a base case around $1.11 and support toward $0.6273 — roughly +26% from $0.879. Buyers look set to stay in control over this stretch.
Expect VBIO to range from $0.5461 to $1.92 through 2033. The $1.01 average target implies a +15% move from current prices. That is -9% versus the projected 2032 average. Price action looks broadly range-bound.
The VBIO price prediction for 2034 points to an average of $0.9747 (low $0.5078, high $1.91) — a potential gain of +11% on today's $0.879. A consolidation phase looks the most probable path here.
In 2035, VBIO is projected to trade between $0.4786 and $1.91, averaging $0.9549 — a potential gain of +9% from today's $0.879. That is -2% versus the projected 2034 average. Price action looks broadly range-bound.
Valion Bio, Inc.'s 2040 outlook centres on $1.24, within a $0.5579 to $2.73 range. That is up +30% on the projected 2035 average. That marks a +41% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, VBIO could reach as high as $7.52, with a base case around $3.27 and support toward $1.47 — roughly +272% from $0.879. Momentum favours further upside here.
Investing $1,000 in VBIO today (≈ 1,137.656428 VBIO) could be worth
$3,717.28
+$2,717.28 (+272%) by 2050 · US Dollar
Based on the average projected VBIO price of $3.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VBIOwould be worth at today's price.
$1,000 invested in VBIO on May 27, 2025 (≈ 242.718453 VBIO) would be worth
$213.35
-$786.65 (-78.7%) today · 0.21× · US Dollar
Based on a VBIO entry price of $4.12 vs. today's $0.879.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.875 | $1,004.57 | +0.5% |
| 1 month ago | $1.4 | $627.86 | -37.2% |
| 3 months ago | $0.837 | $1,050.18 | +5.0% |
| 6 months ago | $1.82 | $484.3 | -51.6% |
| 1 year ago | $4.12 | $213.35 | -78.7% |
| All time (4.5y) ago | $8,823 | $0.1 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VBIO forecast.
Our base-case forecast reaches $1.80 around 2050.
Implied market cap at $1.80: $5.76M
The multi-year forecast shows a path from a 2026 average price near current levels to higher levels later. By 2030 the average is $1.07 with a 25.6% ROI and bullish sentiment; by 2040 the average is $1.22 with a 43% ROI and bullish sentiment; by 2050 the average is $3.18 with a 272.6% ROI and bullish sentiment. The forecast also shows near-term volatility, including negative ROIs in 2027 (-18.5%) and 2028 (-21%), before turning higher in 2029 and beyond.
Tap a question to reveal the answer.
2030 forecast: average price $1.07 with a 25.6% ROI and bullish sentiment.
Forecasts show mixed near-term results, including negative ROIs in 2027 (-18.5%) and 2028 (-21%), before positive ROIs in 2029 (16.7%) and 2030 (25.6%) with bullish sentiment; longer term, 2040 (43%) and 2050 (272.6%) are bullish.
The max forecast by 2050 is $7.30 with a 272.6% ROI and bullish sentiment, and the 2040 max is $2.68; reaching $5 would occur within the 2050 horizon per the forecast, though these are estimates.
Current price is $0.8524 and market cap is $2.73M.
The near-term technical picture is bearish. RSI(14) is 40; price is below SMA(50) at $1.00 and SMA(200) at $1.83; support is at $0.812 and resistance at $1.40; 30-day range is $0.5502 to $1.32.
Valion Bio, Inc. Community Discussion
0Share your Valion Bio, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.